Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?

Busula1, Annette3,4; Berge1, Jet ten; van Dijk1, Tessa S; Takken1, Willem; De de Boer1, Jetske G2*

Home
→
Research Papers
→
SCHOOL OF SCIENCE
→
View Item

dc.contributor.author	Busula1, Annette3,4
dc.contributor.author	Berge1, Jet ten
dc.contributor.author	van Dijk1, Tessa S
dc.contributor.author	Takken1, Willem
dc.contributor.author	De de Boer1, Jetske G2*
dc.date.accessioned	2019-07-05T06:32:54Z
dc.date.available	2019-07-05T06:32:54Z
dc.date.issued	2019
dc.identifier.citation	1. WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World Health Organization; 2015. p. 314. 2. WHO. World Malaria Report 2017. Geneva: World Health Organization; 2017. 3. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–11. 4. Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Artemisinin-based combination therapy for treating uncomplicated malaria. Cochrane Database Syst Rev. 2009;3:CD007483. 5. Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ. Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J. 2008;7:125. 6. Price RN, Nosten F, Luxemburger C, Ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet. 1996;347:1654–8. 7. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, et al. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J. 2010;9:136. 8. Chotivanich K, Sattabongkot J, Udomsangpetch R, Looareesuwan S, Day NPJ, Coleman RE, et al. Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother. 2006;50:1927–30. 9. Ippolito MM, Johnson J, Mullin C, Mallow C, Morgan N, Wallender E, et al. The relative effects of artemether–lumefantrine and non-artemisinin antimalarials on gametocyte carriage and transmission of Plasmodium falciparum: a systematic review and meta-analysis. Clin Infect Dis. 2017;65:486–94. 10. Bousema JT, Schneider P, Gouagna LC, Drakeley CJ, Tostmann A, Houben R, et al. Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis. 2006;193:1151–9. 11. Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, Alexander N, et al. Reduction of malaria transmission to Anopheles mosquitoes with a sixdose regimen of co-artemether. PLoS Med. 2005;2:338–46. 12. Targett G, Drakeley C, Jawara M, Seidlein L, Coleman R, Deen J. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis. 2001;183:1254–9. 13. Sawa P, Shekalaghe SA, Drakeley CJ, Sutherland CJ, Mweresa CK, Baidjoe AY, et al. Malaria transmission after artemether–lumefantrine and dihydroartemisinin–piperaquine: a randomized trial. J Infect Dis. 2013;207:1637–45. 14. Abdulla S, Achan J, Adam I, Alemayehu BH, Allan R, Allen EN, et al. Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med. 2016;14:79. 15. Sinka ME, Bangs MJ, Manguin S, Coetzee M, Mbogo CM, Hemingway J, et al. The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic precis. Parasit Vectors. 2010;3:317. 16. Takken W, Verhulst NO. Host preferences of blood-feeding mosquitoes. Annu Rev Entomol. 2013;58:433–53. 17. Busula AO, Takken W, Loy DE, Hahn BH, Mukabana WR, Verhulst NO. Mosquito host preferences affect their response to synthetic and natural odour blends. Malar J. 2015;14:133. 18. Robinson A, Busula AO, Voets MA, Beshir KB, Caulfield JC, Powers SJ, et al. Plasmodium-associated changes in human odor attract mosquitoes. Proc Natl Acad Sci USA. 2018;15:E4209–18. 19. Ferguson HM, Read AF. Why is the effect of malaria parasites on mosquito survival still unresolved? Trends Parasitol. 2002;18:256–61. 20. Coetzee M, Hunt RH, Wilkerson R, Della Torre A, Coulibaly MB, Besansky NJ. Anopheles coluzzii and Anopheles amharicus, new members of the Anopheles gambiae complex. Zootaxa. 2013;3619:246–74. de Boer et al. Malar J (2019) 18:28 Page 10 of 10 • fast, convenient online submission • thorough peer review by experienced researchers in your field • rapid publication on acceptance • support for research data, including large and complex data types • gold Open Access which fosters wider collaboration and increased citations • maximum visibility for your research: over 100M website views per year At BMC, research is always in progress. Learn more biomedcentral.com/submissions Ready to submit your research ? Choose BMC and benefit from: 21. de Boer JG, Robinson A, Powers SJ, Burgers SLGE, Caulfield JC, Birkett MA, et al. Odours of Plasmodium falciparum-infected participants influence mosquito-host interactions. Sci Rep. 2017;7:9283. 22. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, Dorosario VE, et al. High-sensitivity of detection of human malaria parasites by the use of nested polymerase chain-reaction. Mol Biochem Parasitol. 1993;61:315–20. 23. Eastman RT, Fidock DA. Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria. Nat Rev Microbiol. 2009;7:864–74. 24. Lefevre G, Thomsen MS. Clinical pharmacokinetics of artemether and lumefantrine (Riamet (R)). Clin Drug Invest. 1999;18:467–80. 25. Verhulst NO, Qiu YT, Beijleveld H, Maliepaard C, Knights D, Schulz S, et al. Composition of human skin microbiota affects attractiveness to malaria mosquitoes. PLoS ONE. 2011;6:e28991. 26. Menger DJ, Otieno B, de Rijk M, Mukabana WR, van Loon JJA, Takken W. A push-pull system to reduce house entry of malaria mosquitoes. Malar J. 2014;13:119. 27. Busula AO, Takken W, de Boer JG, Mukabana WR, Verhulst NO. Variation in host preference of malaria mosquitoes is mediated by skin bacterial volatiles. Med Vet Entomol. 2017;31:320–6. 28. Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77:181–92. 29. Ezzet F, van Vugt M, Nosten F, Looareesuwan S, White NJ. Pharmacokinetics and pharmacodynamics of lumefantrine (Benflumetol) in acute falciparum malaria. Antimicrob Agents Chemother. 2000;44:697–704. 30. Takken W, Klowden MJ, Chambers GM. Effect of body size on host seeking and blood meal utilization in Anopheles gambiae sensu stricto (Diptera: Culicidae): the disadvantage of being small. J Med Entomol. 1998;35:639–45. 31. Takken W, Knols BGJ. Odor-mediated behavior of Afrotropical malaria mosquitoes. Annu Rev Entomol. 1999;44:131–57. 32. Lin JT, Lon C, Spring MD, Sok S, Chann S, Ittiverakul M, et al. Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: an open-label randomized trial. PLoS ONE. 2017;12:e0168702. 33. Qiu YT, Smallegange RC, Van Loon JJA, Ter Braak CJF, Takken W. Interindividual variation in the attractiveness of human odours to the malaria mosquito Anopheles gambiae s.s. Med Vet Entomol. 2006;20:280–7. 34. Penn DJ, Oberzaucher E, Grammer K, Fischer G, Soini HA, Wiesler D, et al. Individual and gender fingerprints in human body odour. J R Soc Interface. 2007;4:331–40. 35. Busula AO, Bousema T, Mweresa CK, Masiga D, Logan JG, Sauerwein RW, et al. Gametocytaemia and attractiveness of Plasmodium falciparuminfected Kenyan children to Anopheles gambiae mosquitoes. J Infect Dis. 2017;216:291–5. 36. Lacroix R, Mukabana WR, Gouagna LC, Koella JC. Malaria infection increases attractiveness of humans to mosquitoes. PLoS Biol. 2005;3:1590–3. 37. Batista EPA, Costa EFM, Silva AA. Anopheles darlingi (Diptera: Culicidae) displays increased attractiveness to infected individuals with Plasmodium vivax gametocytes. Parasit Vectors. 2014;7:251. 38. Emami SN, Bo G, Lindberg BG, Hua S, Hill S, Mozuraitis R, et al. A key malaria metabolite modulates vector blood seeking, feeding, and susceptibility to infection. Science. 2017;355:1076–80. 39. Fitch CD. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci. 2004;74:1957–72. 40. Golenser J, Waknine JH, Krugliak M, Hunt NH, Grau GE. Current perspectives on the mechanism of action of artemisinins. Int J Parasitol. 2006;36:1427–41. 41. Lee IS, Hufford CD. Metabolism of antimalarial sesquiterpene lactones. Pharmacol Ther. 1990;48:345–55. 42. Foy BD, Kobylinski KC, da Silva IM, Rasgon JL, Sylla M. Endectocides for malaria control. Trends Parasitol. 2011;27:423–8. 43. Strauss WG, Maibach HI, Khan AA. Drugs and disease as mosquito repellents in man. Am J Trop Med Hyg. 1968;17:461–4.	en_US
dc.identifier.issn	https://doi.org/10.1186/s12936-019-2646-9
dc.identifier.uri	http://erepository.kafuco.ac.ke/123456789/20
dc.description.abstract	Artemisinin-based combination therapy (ACT) is the recommended treatment against uncomplicated Plasmodium falciparum infections, and ACT is widely used. It has been shown that gametocytes may be present after ACT and transmission to mosquitoes is still possible. Artemether–lumefantrine (AL) is a broadly used artemisininbased combination medicine. Here, it is tested whether AL influences behaviour and fitness of Anopheles mosquitoes, which are the main vectors of P. falciparum.	en_US
dc.description.sponsorship	Netherlands Organisation for Health Research and Development (ZonMW, Grant number 91211038	en_US
dc.language.iso	en	en_US
dc.publisher	Netherlands Institute of Ecology	en_US
dc.subject	Skin odour, Olfaction, Host-searching, Antimalarial medication, Epidemiology, Post-treatment transmission, Gametocytes	en_US
dc.title	Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?	en_US
dc.type	Preprint	en_US